chr6-41798842-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001286554.2(USP49):c.1758C>A(p.Asp586Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
USP49
NM_001286554.2 missense
NM_001286554.2 missense
Scores
1
1
17
Clinical Significance
Conservation
PhyloP100: 4.64
Genes affected
USP49 (HGNC:20078): (ubiquitin specific peptidase 49) Enables cysteine-type endopeptidase activity; histone binding activity; and thiol-dependent deubiquitinase. Involved in histone H2B conserved C-terminal lysine deubiquitination and mRNA splicing, via spliceosome. Predicted to be located in nucleoplasm. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08577433).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP49 | NM_001286554.2 | c.1758C>A | p.Asp586Glu | missense_variant | 7/8 | ENST00000682992.1 | NP_001273483.1 | |
USP49 | NM_001384542.1 | c.1758C>A | p.Asp586Glu | missense_variant | 7/8 | NP_001371471.1 | ||
USP49 | NM_018561.5 | c.1758C>A | p.Asp586Glu | missense_variant | 7/7 | NP_061031.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP49 | ENST00000682992.1 | c.1758C>A | p.Asp586Glu | missense_variant | 7/8 | NM_001286554.2 | ENSP00000507239.1 | |||
USP49 | ENST00000373010.5 | c.1725+33C>A | intron_variant | 5 | ENSP00000362101.1 | |||||
ENSG00000288721 | ENST00000684631.1 | n.*1916C>A | non_coding_transcript_exon_variant | 9/10 | ENSP00000507261.1 | |||||
ENSG00000288721 | ENST00000684631.1 | n.*1916C>A | 3_prime_UTR_variant | 9/10 | ENSP00000507261.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 23, 2023 | The c.1758C>A (p.D586E) alteration is located in exon 7 (coding exon 4) of the USP49 gene. This alteration results from a C to A substitution at nucleotide position 1758, causing the aspartic acid (D) at amino acid position 586 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.0040
.;B
Vest4
MutPred
Gain of catalytic residue at D586 (P = 0.2199);Gain of catalytic residue at D586 (P = 0.2199);
MVP
MPC
0.82
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.